King Luther Capital Management Corp Boosts Stake in Avantor, Inc. (NYSE:AVTR)

King Luther Capital Management Corp lifted its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 100.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,000 shares of the company’s stock after purchasing an additional 8,000 shares during the quarter. King Luther Capital Management Corp’s holdings in Avantor were worth $337,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Daiwa Securities Group Inc. lifted its position in Avantor by 1.8% in the fourth quarter. Daiwa Securities Group Inc. now owns 77,428 shares of the company’s stock valued at $1,632,000 after buying an additional 1,346 shares during the last quarter. AlphaQuest LLC purchased a new stake in shares of Avantor in the 4th quarter valued at approximately $65,000. Amundi lifted its holdings in shares of Avantor by 3.8% in the 4th quarter. Amundi now owns 1,752,769 shares of the company’s stock worth $38,789,000 after acquiring an additional 64,781 shares during the last quarter. Rialto Wealth Management LLC purchased a new position in shares of Avantor during the 4th quarter worth approximately $1,779,000. Finally, River Global Investors LLP acquired a new stake in Avantor in the 4th quarter valued at approximately $1,115,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the sale, the executive vice president now owns 87,379 shares of the company’s stock, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

Avantor Stock Up 0.2 %

AVTR stock opened at $15.83 on Friday. The stock has a market cap of $10.78 billion, a P/E ratio of 15.22, a PEG ratio of 1.55 and a beta of 1.30. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a twelve month low of $15.37 and a twelve month high of $28.00. The company’s 50 day moving average is $19.62 and its two-hundred day moving average is $22.12.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the previous year, the firm earned $0.22 earnings per share. Research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. UBS Group restated a “neutral” rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Stifel Nicolaus lowered their target price on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Monday, February 10th. Royal Bank of Canada reduced their price target on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Citigroup lowered their price objective on Avantor from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Finally, Barclays cut their target price on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $25.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.